A carregar...
Outcomes of neoadjuvant chemotherapy using gemcitabine and cisplatin in muscle invasive bladder cancer: A retrospective analysis of the patient and treatment factors in a single institute
BACKGROUND: Meta‐analysis had shown a significant 5% absolute survival benefit in favour of neoadjuvant chemotherapy (NAC) with cisplatin‐based chemotherapy before radical cystectomy (RC) and pelvic lymphadenectomy (PLND) for patients with muscle invasive bladder cancer (MIBC). Those who had patholo...
Na minha lista:
| Publicado no: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941461/ https://ncbi.nlm.nih.gov/pubmed/32721111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1170 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|